CUR is recognized for its ability to induce Bax/Bcl2‐involved apoptosis in cancer cells,16, 42 as evidenced by the elevated levels of Bax, Bax/Bcl2 and cleaved caspase‐3 in both CT26 and HCT116 cells treated with CUR at the 4‐h time point in our study (Figure 3A,C). This evidence concerns the gene BCL2 and cancer.